The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Wender, P. H.
* Articles by Ward, M.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Wender, P. H.
* Articles by Ward, M.

Am J Psychiatry 1985; 142:547-552
Copyright © 1985 by American Psychiatric Association


REGULAR ARTICLES

A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults

PH Wender, FW Reimherr, D Wood and M Ward

Thirty-seven adult patients meeting the Utah criteria for attention deficit disorder, residual type, were entered into a double-blind crossover trial of methylphenidate and placebo. A moderate-to-marked therapeutic response occurred in 21 (57%) of the patients while receiving methylphenidate and in four (11%) while receiving placebo, a highly significant difference statistically and clinically. The responding patients showed significant improvement in the following areas: attentional difficulty, motor overactivity, affective lability, and impulsivity. The diagnosis of attention deficit disorder, residual type, should be considered in patients with prominent complaints of impulsivity, restlessness, emotional lability, and hot temper who do not suffer from schizophrenia or major mood disorder and do not have symptoms of schizotypal or borderline personality disorders.


This article has been cited by other articles:


Home page
J PsychopharmacolHome page
M Koesters, T Becker, R Kilian, J. Fegert, and S Weinmann
Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorder
J Psychopharmacol, September 1, 2009; 23(7): 733 - 744.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
J Godfrey
Safety of therapeutic methylphenidate in adults: a systematic review of the evidence
J Psychopharmacol, March 1, 2009; 23(2): 194 - 205.
[Abstract] [PDF]


Home page
J Atten DisordHome page
L. A. Adler, T. J. Spencer, D. W. Williams, R. J. Moore, and D. Michelson
Long-Term, Open-Label Safety and Efficacy of Atomoxetine in Adults With ADHD: Final Report of a 4-Year Study
J Atten Disord, November 1, 2008; 12(3): 248 - 253.
[Abstract] [PDF]


Home page
Arch. Dis. Child.Home page
J Barton
Atomoxetine: a new pharmacotherapeutic approach in the management of attention deficit/hyperactivity disorder
Arch. Dis. Child., February 1, 2005; 90(suppl_1): i26 - i29.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
J. J. McGough and R. A. Barkley
Diagnostic Controversies in Adult Attention Deficit Hyperactivity Disorder
Am J Psychiatry, November 1, 2004; 161(11): 1948 - 1956.
[Abstract] [Full Text] [PDF]


Home page
FocusHome page
L. L. Greenhill, S. Pliszka, M. K. Dulcan, W. Bernet, V. Arnold, J. Beitchman, R. S. Benson, O. Bukstein, J. Kinlan, J. McClellan, et al.
Practice Parameter for the Use of Stimulant Medications in the Treatment of Children, Adolescents, and Adults
Focus, October 1, 2004; 2(4): 642 - 668.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
T. E. Wilens, S. V. Faraone, and J. Biederman
Attention-Deficit/Hyperactivity Disorder in Adults
JAMA, August 4, 2004; 292(5): 619 - 623.
[Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
I. D Maidment
Efficacy of Stimulants in Adult ADHD
Ann. Pharmacother., December 1, 2003; 37(12): 1884 - 1890.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
M. F. Dorrego, L. Canevaro, G. Kuzis, L. Sabe, and S. E. Starkstein
A Randomized, Double-Blind, Crossover Study of Methylphenidate and Lithium in Adults With Attention-Deficit/Hyperactivity Disorder: Preliminary Findings
J Neuropsychiatry Clin Neurosci, August 1, 2002; 14(3): 289 - 295.
[Abstract] [Full Text] [PDF]


Home page
J Atten DisordHome page
S. Tenenbaum, J.C. Paull, E.P. Sparrow, D.K. Dodd, and L. Green
An experimental comparison of Pycnogenol(R) and methylphenidate in adults with Attention-Deficit/ Hyperactivity Disorder (ADHD)
J Atten Disord, January 1, 2002; 6(2): 49 - 60.
[Abstract] [PDF]


Home page
J Atten DisordHome page
T. E. Wilens, T. J. Spencer, and J. Biederman
A review of the pharmacotherapy of adults with Attention-Deficit/ Hyperactivity Disorder
J Atten Disord, January 1, 2001; 5(4): 189 - 202.
[Abstract] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
B. S. McCann, L. Scheele, N. Ward, and P. Roy-Byrne
Discriminant Validity of the Wender Utah Rating Scale for Attention-Deficit/Hyperactivity Disorder in Adults
J Neuropsychiatry Clin Neurosci, May 1, 2000; 12(2): 240 - 245.
[Abstract] [Full Text] [PDF]


Home page
J Learn DisabilHome page
T. A. Sandson, K. J. Bachna, and M. D. Morin
Right Hemisphere Dysfunction in ADHD: Visual Hemispatial Inattention and Clinical Subtype
J Learn Disabil, January 1, 2000; 33(1): 83 - 90.
[Abstract] [PDF]


Home page
J Atten DisordHome page
L.J. Katz, G. Goldstein, and M. Geckle
Neuropsychological and personality differences between men and women with ADHD
J Atten Disord, November 1, 1998; 2(4): 239 - 247.



Home page
AssessmentHome page
L. J. Katz, D. S. Wood, G. Goldstein, R. C. Auchenbach, and M. Geckle
The Utility of Neuropsychological Tests in Evaluation of Attention-Deficit/ Hyperactivity Disorder (ADHD) versus Depression in Adults
Assessment, March 1, 1998; 5(1): 45 - 51.
[Abstract] [PDF]


Home page
J Atten DisordHome page
K. Murphy and R.A. Barkley
Prevalence of DSM-IV symptoms of ADHD in adult licensed drivers: Implications for clinical diagnosis
J Atten Disord, October 1, 1996; 1(3): 147 - 161.
[Abstract]


Home page
J Atten DisordHome page
R.A. Barkley, K. Murphy, and D. Kwasnik
Psychological adjustment and adaptive impairments in young adults with ADHD
J Atten Disord, April 1, 1996; 1(1): 41 - 54.
[Abstract]


Home page
Arch Gen PsychiatryHome page
R. G. Klein and P. Wender
The Role of Methylphenidate in Psychiatry
Arch Gen Psychiatry, June 1, 1995; 52(6): 429 - 433.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
T. Spencer, T. Wilens, J. Biederman, S. V. Faraone, J. S. Ablon, and K. Lapey
A Double-blind, Crossover Comparison of Methylphenidate and Placebo in Adults With Childhood-Onset Attention-Deficit Hyperactivity Disorder
Arch Gen Psychiatry, June 1, 1995; 52(6): 434 - 443.
[Abstract] [PDF]


Home page
Arch Fam MedHome page
D. C. Vinson
Therapy for Attention-Deficit Hyperactivity Disorder-Reply
Arch Fam Med, October 1, 1994; 3(10): 857 - 858.
[Abstract] [PDF]


Home page
J Child NeurolHome page
M. B. Denckla
Attention Deficit Hyperactivity Disorder- Residual Type
J Child Neurol, January 1, 1991; 6(1_suppl): S44 - S50.
[Abstract] [PDF]


Home page
Journal of Pharmacy PracticeHome page
L. K. Laird and J. J. Saklad
Attention-Deficit Hyperactivity Disorder
Journal of Pharmacy Practice, January 1, 1990; 3(4): 241 - 251.
[Abstract] [PDF]


Home page
Arch Gen PsychiatryHome page
R. J. Chiarello and J. O. Cole
The Use of Psychostimulants in General Psychiatry: A Reconsideration
Arch Gen Psychiatry, March 1, 1987; 44(3): 286 - 295.
[Abstract] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1985 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org